Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
106 INR | +2.12% |
|
+4.90% | +4.85% |
Valuation
Fiscal Period: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Capitalization 1 | 348 | 542.6 | 653 | 690.4 | 796 |
Enterprise Value (EV) 1 | 395.4 | 597.4 | 758 | 790.2 | 896.3 |
P/E ratio | 16.8 x | 18.5 x | 21 x | 20.6 x | 24.2 x |
Yield | - | 0.4% | 0.25% | 0.76% | 0.66% |
Capitalization / Revenue | 0.43 x | 0.56 x | 0.74 x | 0.66 x | 0.76 x |
EV / Revenue | 0.49 x | 0.62 x | 0.86 x | 0.75 x | 0.85 x |
EV / EBITDA | 18.4 x | 21.9 x | 16.3 x | 18.1 x | 19.1 x |
EV / FCF | -6.92 x | -7.23 x | -14.4 x | 2,391 x | -152 x |
FCF Yield | -14.4% | -13.8% | -6.93% | 0.04% | -0.66% |
Price to Book | 2.31 x | 2.54 x | 2.43 x | 2.32 x | 2.45 x |
Nbr of stocks (in thousands) | 7,234 | 7,234 | 8,122 | 8,122 | 8,122 |
Reference price 2 | 48.10 | 75.00 | 80.40 | 85.00 | 98.00 |
Announcement Date | 9/23/19 | 8/28/20 | 8/23/21 | 9/2/22 | 10/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 197 | 811.6 | 964.1 | 885.8 | 1,049 | 1,054 |
EBITDA 1 | 9.572 | 21.51 | 27.23 | 46.37 | 43.55 | 46.95 |
EBIT 1 | 9.107 | 20.78 | 26.22 | 45.2 | 41.03 | 41.41 |
Operating Margin | 4.62% | 2.56% | 2.72% | 5.1% | 3.91% | 3.93% |
Earnings before Tax (EBT) 1 | 9.391 | 29.11 | 41.33 | 44.03 | 46.46 | 45.65 |
Net income 1 | 7.376 | 20.42 | 29.93 | 31.07 | 33.48 | 32.87 |
Net margin | 3.75% | 2.52% | 3.1% | 3.51% | 3.19% | 3.12% |
EPS 2 | 1.640 | 2.866 | 4.060 | 3.826 | 4.120 | 4.047 |
Free Cash Flow 1 | -40.99 | -57.11 | -82.62 | -52.56 | 0.3305 | -5.901 |
FCF margin | -20.81% | -7.04% | -8.57% | -5.93% | 0.03% | -0.56% |
FCF Conversion (EBITDA) | - | - | - | - | 0.76% | - |
FCF Conversion (Net income) | - | - | - | - | 0.99% | - |
Dividend per Share | - | - | 0.3000 | 0.2000 | 0.6500 | 0.6500 |
Announcement Date | 8/31/18 | 9/23/19 | 8/28/20 | 8/23/21 | 9/2/22 | 10/6/23 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 50.7 | 47.4 | 54.8 | 105 | 99.8 | 100 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 5.299 x | 2.204 x | 2.013 x | 2.265 x | 2.292 x | 2.138 x |
Free Cash Flow 1 | -41 | -57.1 | -82.6 | -52.6 | 0.33 | -5.9 |
ROE (net income / shareholders' equity) | 14.5% | 17.9% | 15.3% | 12.2% | 11.8% | 10.6% |
ROA (Net income/ Total Assets) | 1.89% | 3.34% | 3.5% | 5.23% | 4.17% | 3.99% |
Assets 1 | 390.3 | 610.9 | 854.2 | 594.7 | 802.1 | 824 |
Book Value Per Share 2 | 15.10 | 20.80 | 29.50 | 33.20 | 36.60 | 40.00 |
Cash Flow per Share 2 | 2.470 | 0.0800 | 0.0900 | 0.0800 | 0.0500 | 0.0600 |
Capex | - | - | 23.2 | 6.31 | 13.5 | 8.63 |
Capex / Sales | - | - | 2.4% | 0.71% | 1.28% | 0.82% |
Announcement Date | 8/31/18 | 9/23/19 | 8/28/20 | 8/23/21 | 9/2/22 | 10/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+4.85% | 10.1M | |
+22.65% | 69.47B | |
-4.13% | 46.2B | |
+24.91% | 44.48B | |
+38.40% | 29.65B | |
+13.44% | 19.9B | |
+13.96% | 17.23B | |
-28.13% | 14.45B | |
-13.31% | 14.71B | |
-30.89% | 11.89B |
- Stock Market
- Equities
- MAHICKRA Stock
- Financials Mahickra Chemicals Limited